"热点聚焦"标签列表

[EASL2011]肝脏前体细胞标志物与肝损伤相关，且能预测酒精性肝炎的短期死亡率2011-04-02

[EASL2011]在体RNAI筛查肝再生的新调节因子2011-04-02

[EASL2011]肝细胞移植后HGF/C-MET和依赖NEMO的信号通路的抑制对移植物和活性细胞筛选至关重要2011-04-02

[EASL2011]CD39的表达促进CD133+CD45+骨髓干细胞的激活及肝再生2011-04-02

[EASL2011]戊型肝炎病毒（HEV）基因组RNA在跨膜-补体致活的衣壳蛋白内的包被以及感染性病毒颗粒的复制2011-04-02

[EASL2011]吡格列酮在人肝脏中有抗炎作用，并抑制星状细胞活化和增殖2011-04-02

[EASL2011]TELAPREVIR Ⅲ期临床试验中治疗引起耐药变异的病毒演变2011-04-02

[EASL2011]REALIZE研究中TELAPREVIR诱导治疗方案的子分析：第4周的应答不能替代前空应答的分类2011-04-02

[EASL2011]REALIZE研究最终结论：运用Telaprevir治疗聚乙二醇干扰素/利巴韦林联合经治的基因1型HCV感染患者2011-04-02

[EASL2011]人群分析显示HCV病毒逃逸CD8+ T 细胞免疫应答与抗病毒感染相关2011-04-02

[EASL2011]早期结果显示诊断肝硬化患者急性肾损伤标准(AKIN)的优点2011-04-01

[APASL2011]Preventing Perinatal transmission of HBV2011-02-25

[APASL2011]Tenofovir no resistance after 192 weeks2011-02-25

[APASL2011]Regulating liver transplantation for the future2011-02-25

[APASL2011]Liver Fibrosis therapies: Getting to the source of the problem2011-02-25

[APASL2011]HCV Non responders triple therapy for Non responders.2011-02-25

[APASL2011]HBsAg: Ultimate endpoint and ultimate predictor of response?2011-02-25

[APASL2011]HBV Population patterns2011-02-25

[APASL2011]Eating yourself to survival2011-02-25

[APASL2011]What to do for people with HCC contraindicated for people unsuitable for surgery?2011-02-25